416 results on '"Brown, Anna L"'
Search Results
2. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition
3. TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms
4. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
5. Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26
6. Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma
7. Novel modes of MPL activation in triple-negative myeloproliferative neoplasms
8. Genomic subtyping and therapeutic targeting of acute erythroleukemia
9. Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia
10. Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia
11. Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia
12. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer
13. Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)
14. RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML
15. Unravelling Facets of MECOM-Associated Syndrome: Somatic Genetic Rescue, Clonal Hematopoiesis and Phenotype Expansion
16. ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
17. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition
18. A functional interaction between TDP-43 and USP10 reveals USP10 dysfunction in TDP-43 proteinopathies
19. The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
20. Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion
21. DDX41-related myeloid neoplasia
22. Recognition of familial myeloid neoplasia in adults
23. Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss
24. Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy
25. Bismuth-Based Nano- and Microparticles in X-Ray Contrast, Radiation Therapy, and Radiation Shielding Applications
26. Myeloid neoplasms with germline DDX41 mutation
27. TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype
28. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
29. TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
30. Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in RUNX1, GATA2 and DDX41
31. Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Adults with Inherited Myeloid Malignancies
32. Nanoalginates via Inverse-Micelle Synthesis: Doxorubicin-Encapsulation and Breast Cancer Cytotoxicity
33. Facile Synthesis of Ligand-Free Iridium Nanoparticles and Their In Vitro Biocompatibility
34. Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia
35. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
36. Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations
37. The GM-CSF receptor utilizes β-catenin and Tcf4 to specify macrophage lineage differentiation
38. And the germline beat (AML) goes on
39. Childhood acute myeloid leukemia shows a high level of germline predisposition
40. Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common β-subunit
41. Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges
42. Cover, Volume 42, Issue 11
43. To T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition
44. GATA2 deficiency syndrome: A decade of discovery
45. B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations
46. Aqueous red-emitting silicon nanoparticles for cellular imaging: Consequences of protecting against surface passivation by hydroxide and water for stable red emission
47. The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy
48. The aquatic resources of the Hawaiian islands
49. Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival
50. The preferential occurrence of FLT3-TKD mutations in inv(16) AML and impact on survival outcome: a combined analysis of 1053 core-binding factor AML patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.